|Other Names||BTB/POZ domain-containing protein 9, BTBD9, KIAA1880|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Tissue Location||Detected in the brain (at protein level) (PubMed:22658601). Moderately expressed in all specific brain regions examined (PubMed:11572484). Expressed in the dopaminergic neurons of the substantia nigra and A11 neurons (PubMed:22658601) Highly expressed in kidney and moderately expressed in all other adult and fetal tissues (PubMed:11572484)|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This locus encodes a BTB/POZ domain-containing protein. This domain is known to be involved in protein-protein interactions. Polymorphisms at this locus have been reported to be associated with susceptibility to Restless Legs Syndrome and may also be associated with Tourette Syndrome.
Riviere, J.B., et al. Arch. Neurol. 66(10):1267-1272(2009) Schimmelmann, B.G., et al. J Psychiatr Res 43(10):941-945(2009) Kemlink, D., et al. J. Med. Genet. 46(5):315-318(2009) Jones, L.C., et al. Genes Brain Behav. 7(5):513-514(2008)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.